Business & Tech
Isis' Cholestrol Drug Gets FDA Approval
The Carlsbad company's shares were up last week and have gone up steadily since November, gaining about 74 percent.
Carlsbad-based Isis Pharmaceuticals Inc. first company drug, Kynamro, has been given U.S. Food and Drug Administration approval to reach market.
Kynamro is an injectable drug designed to treat patients who are genetically predisposed to have high levels of LDL cholesterol, known as the “bad” cholesterol, wrote the Associated Press.
To read the full article go to: sddt.com/Finance/article.cfm?SourceCode=20130130czb&utm_medium=email&utm_source=NightlyNews&utm_campaign=2013%2D01%2D30&_t=Isis+Pharma+shares+rise+on+Kynamro+approval#.UQ_y8Y5khgM
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here
